Clinical Trials on Cystoid Macular Edema

Total 55145 results

ZeaVision, LLC
Sound Retina

Unknown

Prospective Study of Adjunctive Carotenoids Plus Anti-oxidants in Anti-VEGF Treated Diabetic Macular Edema (PROACTIVEDME)

Center-involved Diabetic Macular Edema (CI-DME)

United States
VISUfarma SpA
CROlife

Completed

VISUPRIME® Eye Drops

Diabetic Macular Edema | Proliferative Diabetic Retinopathy | Macular Degeneration, Age Related | Myopic Choroidal Neovascularisation | Macular Edema of Right Retina (Diagnosis)

Italy
Retina Vitreous Associates of Florida

Completed

Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival

Age-related Macular Degeneration | Central Retinal Vein Occlusion | Diabetic Macular Edema

United States
Daiichi Sankyo, Inc.

Completed

Study of DS-7080a for the Treatment of Macular Degeneration

Diabetic Macular Edema | Neovascular Age-Related Macular Degeneration

United States
JHSPH Center for Clinical Trials
National Eye Institute (NEI)

Completed

Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial (MERIT)

Uveitis | Macular Edema

United States, Australia, Canada, India, United Kingdom
JHSPH Center for Clinical Trials
National Eye Institute (NEI)

Completed

PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial (POINT)

Uveitis | Macular Edema

United States, Canada, United Kingdom, Australia
University of California, San Francisco
Aravind Eye Hospitals, India

Terminated

Macular Edema Nepafenac vs. Difluprednate Uveitis Trial (MEND)

Uveitis | Macular Edema

India
St. Franziskus Hospital

Withdrawn

Autofluorescence in Uveitic and Diabetic Macular Edema

Uveitis | Macular Edema

Germany
University of Utah
Genentech, Inc.

Withdrawn

Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids (SURFING)

Uveitis | Macular Edema

United States
National Eye Institute (NEI)

Completed

Efalizumab to Treat Uveitis

Uveitis | Macular Edema

United States
University Health Network, Toronto

Completed

The Effect of Intravitreal Ozurdex on DME After Cataract Surgery

Diabetic Macular Edema

Canada
European School of Advanced Studies in Ophthalmology

Completed

Influence of Cataract Surgery on Early DME The DICAT-II Study (DICAT-II)

Diabetic Macular Edema | Cataract Senile | Surgery--Complications

Switzerland
Bayer

Recruiting

The SPECTRUM Study: An Observational Study to Learn More About How Well Aflibercept 8 mg Works in Treating Visual Impairment Due to Neovascular Age-related Macular Degeneration or Diabetic Macula Edema

Visual Impairment | Neovascular Age-related Macular Degeneration (nAMD) | Diabetic Macula Edema (DME)

Germany, Canada, Denmark, France, Italy, Saudi Arabia, Switzerland, Australia, Finland, Netherlands, Sweden, Norway, United Arab Emirates, Japan, United Kingdom
Retina Vitreous Associates of Florida
Ocular Therapeutix, Inc.

Terminated

Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections (DETeR)

Diabetic Macular Edema | Retinal Vein Occlusion | Neovascular Age-related Macular Degeneration

United States
Association Pour La Recherche En Vision Du Service...

Unknown

Diabetic Retinopathy Assessed by Ultra-wide (REGARD1)

Diabetic Macular Edema

France
Bayer

Completed

Investigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According to EU Label for DME. (AQUA)

Macular Edema

Spain, Canada, Switzerland, Portugal, Austria, Poland, Slovakia, United Kingdom, France, Czechia, Germany, Hungary, Italy, Lithuania
King Khaled Eye Specialist Hospital

Completed

Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular Edema

Diabetic Macular Edema | Proliferative Diabetic Retinopathy | Non-proliferative Diabetic Retinopathy

Saudi Arabia
Retina Macula Institute
Allergan

Completed

Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema

Diabetic Macular Edema | Proliferative Diabetic Retinopathy | Non-proliferative Diabetic Retinopathy

United States
Kovach Eye Institute

Recruiting

Assessing the Efficacy and Safety fo DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert(s) for the Treatment of Pain, Inflammation, and Cystoid Macular Edema Following 27 Gauge Vitrectomy With Internal Limiting Membrane Peel for the Treatment of Retinal Edema Associated With Macular Pucker.

Vitrectomy | Retinal Edema | Macular Pucker

United States
Astellas Pharma Europe B.V.

Completed

A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME) (VIDI)

Diabetes Mellitus | Diabetic Macular Edema

United States
GlaxoSmithKline

Completed

A First Time in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Healthy Subjects and Stable Heart Failure Patients

Oedema, Pulmonary

United Kingdom
Novartis Pharmaceuticals

Active, not recruiting

Observational Study to Evaluate Fluid Resolution and Effectiveness in Patients Receiving Beovu in Neovascular Age-related Macular Degeneration and Visual Impairment Due to Diabetic Macular Edema (BLUE SKY)

Diabetic Macular Edema (DME) | Neovascular Age-related Macular Degeneration (nAMD)

Germany
Asociación para Evitar la Ceguera en México

Terminated

Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO (MECROV)

Central Retinal Vein Occlusion | Macular Edema

Mexico
Helse Stavanger HF

Terminated

Combined Vitrectomy and Triamcinolone in Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)

Macular Edema | Branch Retinal Vein Occlusion

Norway
Kodiak Sciences Inc

Completed

A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO) (BEACON)

Macular Edema | Retinal Vein Occlusion

Spain, United States, Latvia, Israel, France, Italy, Hungary, Germany, Poland, Slovakia, Puerto Rico, Czechia
Chengdu Kanghong Biotech Co., Ltd.

Completed

Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion (BRAVE)

Macular Edema | Branch Retinal Vein Occlusion

China
Retina Specialists, PC
Allergan

Completed

Ozurdex for Macular Edema Post Membrane Peeling

Macular Edema | Epiretinal Membrane | Retinal Edema | Cellophane Maculopathy

United States
Tianjin Medical University Eye Hospital
Abbvie Pharmaceutical Trading (Shanghai) Co., Ltd.

Recruiting

Compare the Efficacy of VItrectomy Combined With DExamethasone Implant Versus With Aflibercept in DME Patients Diagnosed by Intraoperative OCT (the VIDEO Study): Study Protocol for a Randomized Controlled Trial

Diabetic Macular Edema | Pars Plana Vitrectomy | Dexamethasone Intravitreal Implant | Intraoperative Optical Coherence Tomography

China
Exonate Limited
Novotech (Australia) Pty Limited

Completed

A Study to Evaluate the Safety and Tolerability of EXN407

Diabetic Macular Edema

Australia
Long Island Vitreoretinal Consultants

Completed

Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)

Central Retinal Vein Occlusion | Macular Edema

United States
Retina Research Institute, LLC
Retina-Vitreous Associates Medical Group; West Coast Retina Medical Group,...

Terminated

Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGF

Macular Edema | Retinal Vein Occlusion (RVO)

United States
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion

Macular Degeneration | Macular Edema | Branch Retinal Vein Occlusion

Japan
Fovea Pharmaceuticals SA

Terminated

Study to Assess the Safety and Tolerability of a Single Administration of FOV2302 (Ecallantide) in Patients With Macular Edema Associated With Central Retinal Vein Occlusion (FOV2302)

Central Retinal Vein Occlusion | Macular Edema

France
GWT-TUD GmbH
Novartis

Completed

Intra-individual Variability and Circadian Rhythm of VEGF Levels and Interaction With Biomarkers

Diabetic Macular Edema

Germany
Targeted Therapy Technologies, LLC

Recruiting

Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole

Macula Edema | Epiretinal Membrane | Branch Retinal Vein Occlusion | Radiation Retinopathy | Central Serous Retinopathy With Pit of Optic Disc | Commotio Retinae | Vitritis

United States
Unity Biotechnology, Inc.

Recruiting

Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE) (ASPIRE)

Eye Diseases | Diabetes Mellitus | Retinal Degeneration | Retinal Diseases | Edema | Diabetic Retinopathy | Diabetic Macular Edema | Macular Edema | Retinal Disease

United States
Hoffmann-La Roche
Chugai Pharmaceutical

Completed

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion (BALATON)

Macular Edema | Branch Retinal Vein Occlusion

United States, Korea, Republic of, Brazil, Japan, United Kingdom, China, Argentina, Australia, France, Germany, Hungary, Italy, Poland, Spain, Singapore, Austria, Czechia, Hong Kong, Israel, Portugal, Russian Federation, Taiwan
Aleris Helse
Novartis

Completed

A Randomized Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVO

Central Retinal Vein Occlusion | Macular Edema

Norway
Fondazione G.B. Bietti, IRCCS

Recruiting

Micropulsed Laser in Patients With Macular Oedema in Retinal Dystrophies

Macular Edema | Inherited Retinal Dystrophy | Laser Retinopathy

Italy
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema (KINGFISHER)

Diabetic Macular Edema

United States, Hungary, Israel, Slovakia, Puerto Rico
Novartis Pharmaceuticals

Completed

A 12-month, Randomized, Efficacy and Safety Study of 0.5 mg Ranibizumab vs Laser in Chinese Diabetic Macular Edema (DME) Patients (REFINE)

Diabetic Macular Edema | Visual Impairment

China
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema (KESTREL)

Diabetic Macular Edema

United States, Austria, Japan, Australia, Spain, Canada, Israel, Netherlands, Italy, United Kingdom, Portugal, Colombia, Puerto Rico, Argentina
Hacettepe University

Completed

Advanced Glycation End Products Are Associated With Diabetic Macular Edema

Diabetes Mellitus, Type 2 | Diabetic Macular Edema

Turkey
Retinal Care Inc.
Dean A. McGee Eye Institute

Active, not recruiting

PROTECT2: Diabetes Care - Eye Exam

Diabetic Retinopathy | Diabetic Macular Edema

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

The Course of Response to Focal Photocoagulation for DME (Laser Resp)

Diabetic Retinopathy | Diabetic Macular Edema

United States
Sheba Medical Center
Assaf-Harofeh Medical Center

Unknown

Conjunctival Flora Patterns After Serial Intravitreal Injections in Diabetic Patients

Diabetic Retinopathy | Diabetic Macular Edema

Israel
California Retina Consultants

Completed

Povidone Iodine vs AVEnova: A Pre-injection Disinfection Study (PAVE Study) (PAVE)

Diabetic Retinopathy | Age-related Macular Degeneration | Diabetic Macular Edema

United States
University Hospital, Ghent

Recruiting

Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular Edema

Macular Edema | Retinal Neovascularization

Belgium
St. Franziskus Hospital

Completed

Microperimetry in Macular Edema

Uveitis | Macular Edema

Germany
Regeneron Pharmaceuticals

Completed

Study to Evaluate an 8 mg Aflibercept (EYLEA®) Prefilled Syringe (PFS)

Diabetic Macular Edema (DME) | Neovascular Age-Related Macular Degeneration (nAMD)

United States

Clinical Trials on Cystoid Macular Edema

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations